Literature DB >> 19115382

GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background.

Sanna-Maria Hede1, Inga Hansson, Gijs B Afink, Anna Eriksson, Inga Nazarenko, Johanna Andrae, Guillem Genove, Bengt Westermark, Monica Nistér.   

Abstract

Glioblastomas are the most common and malignant astrocytic brain tumors in human adults. The tumor suppressor gene TP53 is commonly mutated and/or lost in astrocytic brain tumors and the TP53 alterations are often found in combination with excessive growth factor signaling via PDGF/PDGFRalpha. Here, we have generated transgenic mice over-expressing human PDGFB in brain, under control of the human GFAP promoter. These mice showed no phenotype, but on a Trp53 null background a majority of them developed brain tumors. This occurred at 2-6 months of age and tumors displayed human glioblastoma-like features with integrated development of Pdgfralpha+ tumor cells and Pdgfrbeta+/Nestin+ vasculature. The transgene was expressed in subependymal astrocytic cells, in glia limitans, and in astrocytes throughout the brain substance, and subsequently, microscopic tumor lesions were initiated equally in all these areas. With tumor size, there was an increase in Nestin positivity and variability in lineage markers. These results indicate an unexpected plasticity of all astrocytic cells in the adult brain, not only of SVZ cells. The results also indicate a contribution of widely distributed Pdgfralpha+ precursor cells in the tumorigenic process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19115382     DOI: 10.1002/glia.20837

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  30 in total

1.  HIV-1 Tat-mediated induction of platelet-derived growth factor in astrocytes: role of early growth response gene 1.

Authors:  Crystal Bethel-Brown; Honghong Yao; Shannon Callen; Young Han Lee; Prasanta K Dash; Anil Kumar; Shilpa Buch
Journal:  J Immunol       Date:  2011-03-02       Impact factor: 5.422

Review 2.  Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Brain Pathol       Date:  2011-07-07       Impact factor: 6.508

Review 3.  Review: insights gained from modelling high-grade glioma in the mouse.

Authors:  S L Rankin; G Zhu; S J Baker
Journal:  Neuropathol Appl Neurobiol       Date:  2012-06       Impact factor: 8.090

4.  Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability.

Authors:  Honghong Yao; Ming Duan; Shilpa Buch
Journal:  Blood       Date:  2010-12-08       Impact factor: 22.113

5.  Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy.

Authors:  Wei Li; Jian Tan; Peng Wang; Ning Li; Chengxia Li
Journal:  Mol Cell Biochem       Date:  2014-11-20       Impact factor: 3.396

Review 6.  Genetic modeling of gliomas in mice: new tools to tackle old problems.

Authors:  Dolores Hambardzumyan; Luis F Parada; Eric C Holland; Al Charest
Journal:  Glia       Date:  2011-02-08       Impact factor: 7.452

Review 7.  Mouse models of glioblastoma: lessons learned and questions to be answered.

Authors:  Loury Janbazian; Jason Karamchandani; Sunit Das
Journal:  J Neurooncol       Date:  2014-02-13       Impact factor: 4.130

8.  p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.

Authors:  Ryan C Widau; Yanbin Zheng; Caroline Y Sung; Anna Zelivianskaia; Lauren E Roach; Karen M Bachmeyer; Tatiana Abramova; Aurelie Desgardin; Andrew Rosner; John M Cunningham; Stephen X Skapek
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

Review 9.  Glial progenitors as targets for transformation in glioma.

Authors:  Shirin Ilkhanizadeh; Jasmine Lau; Miller Huang; Daniel J Foster; Robyn Wong; Aaron Frantz; Susan Wang; William A Weiss; Anders I Persson
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

Review 10.  What underlies the diversity of brain tumors?

Authors:  Fredrik J Swartling; Sanna-Maria Hede; William A Weiss
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.